Usefulness of a new immunoradiometric assay of HCV core antigen to predict virological response during PEG-IFN/RBV combination therapy for chronic hepatitis with high viral load of serum HCV RNA genotype 1b.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples